# About Youth Lab Peptides — An Independent Aging-Research Desk

> About Youth Lab Peptides: an independent literature digest on four Research Peptide Fundamentals compounds. How it is compiled, what it covers, and what it is not — not a seller, not a clinic, not medical advice.

An independent, citation-anchored digest of healthspan and cellular-aging peptide research. Not a vendor. Not a clinic. Not medical advice.

## What Youth Lab Peptides is

Youth Lab Peptides is an independent editorial reference desk covering the published research on four peptides and peptide-adjacent compounds studied through a **healthspan and cellular-aging** lens: BPC-157, NAD+, semaglutide, and Thymosin Alpha-1, with NAD+ as the lead entry. The desk exists to make a fast-moving and frequently overstated literature legible — to tell a reader, in plain language and with citations, what each compound was actually studied for, in which population, and how far that evidence honestly reaches.

The four compounds do not share a mechanism or a regulatory category. What unites them is that each has become part of the wider conversation about aging well: tissue repair, cellular energy metabolism, metabolic protection, and immune resilience. Reading them side by side clarifies what each contributes and, just as importantly, how differently mature their human evidence actually is — from semaglutide's large randomized trials to BPC-157's three small pilot studies.

## How it is compiled

Three principles govern what appears on this site. First, every research claim is anchored to a numbered citation — peer-reviewed journal articles and clinical-trial publications, with DOIs and PubMed links, collected on the [references page](/references). Second, evidence is described at its actual strength: a Phase 2 trial is labeled as such, a rodent finding is labeled as such, and a null result — like the 2025 sepsis trial for Thymosin Alpha-1 — is reported as plainly as a positive one. Third, the four compound pages are cross-referenced to one another and to a single [comparison page](/compare), so a reader can follow a theme — evidence maturity, regulatory status, safety signal — across the whole desk rather than reading each page in isolation.

## What it is not

Youth Lab Peptides is not a pharmacy, a clinic, a telehealth platform, or a vendor of any kind. It does not sell, supply, or broker any compound, and has no affiliate relationship with any pharmaceutical company, supplement brand, or research-chemical vendor. It does not diagnose conditions or recommend a dose, schedule, or route of administration for any person. Semaglutide is an approved prescription medicine available only through licensed medical providers; NAD+ precursors are marketed as dietary supplements; BPC-157 and Thymosin Alpha-1 fall outside the US approved-drug supply chain in different ways, described on their respective pages. Readers seeking clinical guidance should consult a licensed healthcare provider. Editorial correspondence can be directed to the [contact page](/contact).

---

Youth Lab Peptides is an independent, citation-anchored reading room on healthspan and cellular-aging research — not a clinic, not a supplier, and not a source of medical advice.